期刊文献+

IGF-1R抑制剂NVP-AEW541在肾上腺皮质癌SW13细胞系中的作用

The effect of IGF-1R inhibitor NVP-AEW541 on adrenocortical carcinoma SW13 cell line
暂未订购
导出
摘要 目的通过细胞实验,探寻IGF-1R抑制剂NVP-AEW541阻断IGFR信号通路的激活,评价其对SW13细胞增殖、凋亡的影响情况。方法通过MTT试验观察细胞增殖,通过流式细胞仪检测细胞凋亡的改变,通过Western blot检测IGFR下游信号通路成员ERK和mTOR的表达情况。结果 NVP-AEW541可以呈浓度-时间依赖性抑制细胞增殖、呈浓度依赖性促进细胞早期凋亡和晚期坏死,并下调p-AKT的表达水平,而不影响mTOR的磷酸化水平和RAS/RAF/ERK信号传导通路。结论 IGF-1R抑制剂NVP-AEW541可以通过下调AKT的磷酸化水平,从而抑制细胞增殖、促进细胞凋亡,具有潜在的抗肿瘤作用。 Objective To explore the effect of NVP-AEW541 on adrenocortical carcinoma(ACC) cell line SW13 in vitro. Methods After SW13 cells were treated with NVP-AEW541,the proliferation and apoptosis were detected with MTT assay and flow cytometryrespectively. The expressions of ERK and roTOR were detected with Western blotting. Results NVP- AEW541inhibitedtheproliferationin a dose- and time-dependent manner, promotedtheapoptosis in a dose-dependent manner, down-regulatedthelevel of p-AKT protein expression, but did not affect the expression of p-mTOR protein and RAS/RAF/ ERK signaling pathway. Conclusions NVP-AEW541 is effective to inhibit SW13 proliferation and promote SW13 apoptosis by reducing the expression level of p-AKT. It has anti-tumor potential.
出处 《现代泌尿外科杂志》 CAS 2016年第9期709-712,共4页 Journal of Modern Urology
基金 国家自然科学基金(No.81272936) 上海市科委医学引导项目基金(No.134119a2700)
关键词 SW13 NVP—AEW541 胰岛素样生长因子 PI3K信号通路 SW13 NVP-AEW541 insulin-like growth factor PI3K signaling pathway
  • 相关文献

参考文献17

  • 1LIBE R. Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment[J]. Front Cell Dev Biol, 2015,3:45.
  • 2SOON PS, MCDONALD KL, ROBINSON BG, et al. Molecular markers and the pathogenesis of adrenocortical cancer[J]. Oncologist, 2008,13(5):548-561.
  • 3BUSUND LT, OW KT, RUSSELL P, et al. Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential[J]. Virchows Arch, 2004,444(2):142-148.
  • 4POLLAK M. Insulin-like growth factor-related signaling and cancer development[J]. Recent Results Cancer Res, 2007,174:49-53.
  • 5HAKAM A, YEATMAN TJ, LU L, et al. Expression of insulin-like growth factor-1 receptor in human colorectal cancer[J]. Hum Pathol, 1999,30(10):1128-1133.
  • 6ALL-ERICSSON C, GIRNITA L, SEREGARD S, et al. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target[J]. Invest Ophthalmol Vis Sci, 2002,43(1):1-8.
  • 7TURNER BC, HAFFTY BG, NARAYANAN L, et al. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation[J]. Cancer Res, 1997,57(15):3079-3083.
  • 8ILVESMAKI V, BLUM WF, VOUTILAINEN R. Insulin-like growth factor binding proteins in the human adrenal gland[J]. Mol Cell Endocrinol, 1993,97(1-2):71-79.
  • 9FOTTNER C, ENGELHARDT D, ELMLINGER MW, et al. Identification and characterization of insulin-like growth factor (IGF)-binding protein expression and secretion by adult human adrenocortical cells: differential regulation by IGFs and adrenocorticotropin[J]. J Endocrinol, 2001,168(3):465-474.
  • 10KIRSCHNER LS. Emerging treatment strategies for adrenocortical carcinoma: a new hope[J]. J Clin Endocrinol Metab, 2006,91(1):14-21.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部